Loading Events

Current Understanding Of IgA Nephropathy (IgAN)

Thank you for attending, we hope you enjoyed this webinar.

Please tell us what you thought about today’s presentation by taking the survey below:

Current Understanding Of IgA Nephropathy (IgAN)


IgA Nephropathy (IgAN) is an autoimmune disease characterized by the production of abnormal IgA, an immune response, and deposits of IgA-containing immune complexes in glomeruli causing damage1. Which left unaddressed, the relentless damage to glomeruli can lead to kidney failure and the need for renal replacement therapy, such as transplant or dialysis2. The current model of pathogenicity involves four hits that drive the disease development and progression2.

Did You Know?

  • Immunoglobulin A Nephropathy (IgAN), also known as Berger’s disease, is the most common glomerulonephritis worldwide1
  • Of those affected with IgAN, 20-40% progress to kidney failure1
Why Attend This Webinar?
  • Join us for our webinar where expert, Dr. Ankur Shah, will provide an overview of IgA Nephropathy
What You Will Learn 
  • Prevalence, epidemiology, and pathogenesis of IgAN
  • Signs and symptoms of IgAN
  • Diagnosis and general management strategies of IgAN per KDIGO guidelines
  1. NephU_Overview of IgAN_2022 Infographic – US.CORP.X.22.00054
  2. NephU_The “Four Hit” IgA Nephropathy (IgAN) Pathogenesis Theory_2022 Infographic – US.CORP.X.22.00055


Ankur Shah

Ankur Shah, MD

Assistant Professor of Medicine and Associate Program Director of the Nephrology Fellowship training program

Warren Alpert Medical School, Brown University*

Ankur Shah, MD is Assistant Professor of Medicine and Associate Program Director of the Nephrology Fellowship training program at the Warren Alpert Medical School of Brown University. He completed residency in internal medicine at Temple University Hospital, followed by fellowship at the Hospital of the University of Pennsylvania, where he served as chief fellow and received advanced training in medical education. His primary interests are home dialysis including both peritoneal dialysis and home hemodialysis, topics in which he has published numerous peer reviewed articles as well as textbook chapters and has lectured both nationally and internationally. He is a decorated educator having mentored dozens of medical students, residents, and fellows and received the dean’s excellence in teaching award, department of medicine teaching award, and nephrology fellowship teaching awards at Brown and is a winner of the American Society of Nephrology’s Innovations in Kidney Education contest. He is a Fellow of the American Society of Nephrology, the National Kidney Foundation, and the American College of Physicians.


Josh Gariboldi

Josh Gariboldi, PharmD, BCPS

Nephrology Senior Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Josh Gariboldi, PharmD, BCPS joined Otsuka in January 2021 and is a Medical Science Liaison on our Nephrology East Team, covering the Carolinas and Tennessee. Dr Gariboldi earned his Doctor of Pharmacy degree from the University of Florida in 2012. He has more than eight years of experience as a clinical pharmacist in both the community and hospital settings, most recently at Bon Secours Mercy Health St. Francis Hospital in Greenville, SC. Dr Gariboldi served as a preceptor with Presbyterian College School of Pharmacy, where he instructed students on Advanced Pharmacy Practice rotations. He holds board certifications in both pharmacotherapy and medical affairs.

Hannah N. Lambert

Hannah N. Lambert, PharmD

Nephrology Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Hannah N. Lambert is a Medical Science Liaison at Otsuka Pharmaceutical Development and Commercialization. She earned her Doctor of Pharmacy and completed her clinical residency training at Xavier University of Louisiana College of Pharmacy in New Orleans, LA. Prior to joining Otsuka, Dr Lambert was a clinical pharmacist at Ochsner Health in Digital Medicine.

*Dr Shah is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Drs Josh Gariboldi and Hannah Lambert are employees of OPDC.


Related Resources

Join Today for Instant Access to all NephU Offerings.

Membership is free!

Join NephU today at no cost to register for this event and access to other premium content.

  • The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
  • Quickly learn more about the topics that interest you.
  • Access our library of on-demand kidney health resources
  • Gain key insights from industry experts & though leaders.